Journal of Pharmacological Sciences (May 2020)

Liver hydrolysate improves depressive-like behavior in olfactory bulbectomized mice: Involvement of hippocampal neurogenesis through the AMPK/BDNF/CREB pathway

  • Osamu Nakagawasai,
  • Kotaro Yamada,
  • Takayo Odaira,
  • Kohei Takahashi,
  • Wataru Nemoto,
  • Wakana Sakuma,
  • Miharu Wakou,
  • Jia-Rong Lin,
  • Koichi Tan-No

Journal volume & issue
Vol. 143, no. 1
pp. 52 – 55

Abstract

Read online

Recently, we has reported that AMPK activator has antidepressant effect. Previous our study suggested that liver hydrolysate (LH) activated adenosine monophosphate-activated protein kinase (AMPK) in periphery. However, the effect of LH on depression is unclear. Therefore, we examines whether LH has antidepressant effect on olfactory bulbectomized (OBX) mice. OBX mice showed depressive-like behavior in tail-suspension test and reduction of hippocampal neurogenesis, while these changes were reversed by LH. LH enhanced hippocampal phosphate-AMPK, brain-derived neurotrophic factor (BDNF) and phosphate-cyclic adenosine monophosphate response element-binding protein (CREB) in OBX mice. These data indicate that LH may produce antidepressant effects via hippocampal AMPK/BDNF/CREB signaling. Keywords: Antidepressant, Olfactory bulbectomy, Liver hydrolysate